Sponsor:
Fox Chase Cancer Center
Code:
NCT06782581
Conditions
Neoplasm
Eligibility Criteria
Sex: All
Age: 21 - 70+
Healthy Volunteers: Accepted
Interventions
Contribution to Caregivers Well-Being
Control
Brief summary:
Conditions
Neoplasm
Study ID
NCT06782581
Start date
Aug 6, 2024
Status verified date
Dec, 2025
Completion date
Feb 15, 2027
Anticipated
Primary completion date
Jan 15, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 21 - 70+
Healthy Volunteers: Accepted
Enrollment
186 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Contribution
placebo comparator: Control Group
Interventions
Contribution to Caregivers Well-Being
Control
Primary outcome measure
Central contacts
Locations
Fox Chase Cancer Center - Philadelphia
Recruiting
Philadelphia, Pennsylvania, United States, 19111
Contacts
Sponsor
Fox Chase Cancer Center
Last update posted
Dec 31, 2025
Last verified
Dec, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Fox Chase Cancer Center on 2025-12-31.